Viewing Study NCT06243588



Ignite Creation Date: 2024-05-06 @ 8:04 PM
Last Modification Date: 2024-10-26 @ 3:20 PM
Study NCT ID: NCT06243588
Status: RECRUITING
Last Update Posted: 2024-02-06
First Post: 2024-01-29

Brief Title: Identification of Prognostic Factors and Role of Radiotherapy in Patients With Ewing Sarcoma
Sponsor: Istituto Ortopedico Rizzoli
Organization: Istituto Ortopedico Rizzoli

Study Overview

Official Title: Identification of Prognostic Factors and Role of Radiotherapy in Patients With Ewing Sarcoma
Status: RECRUITING
Status Verified Date: 2024-01
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: assess whether there is a correlation between some factors age sex tumor volume tumor site chemotherapy-induced necrosis radiation and biomarkers and overall survival OS and relapse-free survival RFS in patients with Ewing sarcoma

Identification of reliable prognostic factors could help to identify high-risk patients which may require a different treatment and follow up
Detailed Description: None

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None